CAS: 2290608-13-6
| Marchio | Dati del prodotto | Purezza | Fascia di prezzo | Consegna prevista |
|---|---|---|---|---|
 | N-Methyl-3-(1-methyl-1H-imidazol-4-yl)-4-((4-(trifluoromethyl)phenyl)amino)benzenesulfonamide REF: 3D-QRD60813CAS: 2290608-13-6 | Min. 95% | Prezzo su richiesta | Ven 17 Gen 25 |
 | VT103 REF: TM-T62077CAS: 2290608-13-6 | 98.73% | 121,00 €~3.690,00 € | Ven 24 Gen 25 |
N-Methyl-3-(1-methyl-1H-imidazol-4-yl)-4-((4-(trifluoromethyl)phenyl)amino)benzenesulfonamide
CAS:2290608-13-6
Please enquire for more information about N-Methyl-3-(1-methyl-1H-imidazol-4-yl)-4-((4-(trifluoromethyl)phenyl)amino)benzenesulfonamide including the price, delivery time and more detailed …
Formula:
C18H17F3N4O2S
Purezza:
Min. 95%
Peso molecolare:
410.4 g/mol
Ref: 3D-QRD60813
| 10mg | Prezzo su richiesta | ||
| 25mg | Prezzo su richiesta | ||
| 50mg | Prezzo su richiesta |
Consegna stimata in Stati Uniti, il Venerdì 17 Gennaio 2025
VT103
CAS:2290608-13-6
VT103, an oral TEAD1 palmitoylation inhibitor, shows promise against various cancers by disrupting YAP/TAZ-TEAD interactions.
Formula:
C18H17F3N4O2S
Purezza:
98.73%
Colore e forma:
Liquid
Peso molecolare:
410.41
Ref: TM-T62077
| 1mg | 121,00 € | ||
| 5mg | 291,00 € | ||
| 10mg | 461,00 € | ||
| 25mg | 828,00 € | ||
| 50mg | 1.345,00 € | ||
| 100mg | 1.841,00 € | ||
| 1mL*10mM (DMSO) | 320,00 € |
Consegna stimata in Stati Uniti, il Venerdì 24 Gennaio 2025
